Full Spectrum Microbiota
CDI-001
Phase 2 small_molecule completed
Quick answer
Full Spectrum Microbiota for Clostridium Difficile Infection Recurrence is a Phase 2 program (small_molecule) at Finch Therapeutics Group with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Finch Therapeutics Group
- Indication
- Clostridium Difficile Infection Recurrence
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed